Landscapes / Targets
IL-2 β/γ
20 drugs act on IL-2 β/γ, in 41 active trials · Any stage · updated 18 Nov 2026
FollowEvery change as it happens, and a Monday email
Drugs20
| Drug | How it works | Company | Stage
Sources: FDA: the drug development process, ClinicalTrials.gov glossary | Next date
| Details |
|---|---|---|---|---|---|
PD-1/IL-2 bispecific fusion protein |
Innovent +1 · Public 1801.HK |
Phase 3 | 30 Nov 2026soonPhase 2 trial completes | ||
| Next date | 30 Nov 2026 · Phase 2 trial completes | ||||
| Also tested for | Melanoma, Colorectal Cancer and 9 more | ||||
| Open drug page | |||||
— |
Phase 3 | May 2028Phase 3 trial completes | |||
| Next date | May 2028 · Phase 3 trial completes | ||||
| Also tested for | Moderate-to-Severe Atopic Dermatitis, Moderate to Severe Atopic Dermatitis | ||||
| Open drug page | |||||
— |
Phase 1/2 | 28 Feb 2027Phase 1/2 trial completes | |||
| Next date | 28 Feb 2027 · Phase 1/2 trial completes | ||||
| Also tested for | Advanced Solid Tumor, Metastatic Cancer and 2 more | ||||
| Open drug page | |||||
— |
Phase 1/2 | Feb 2027Phase 1/2 trial completes | |||
| Next date | Feb 2027 · Phase 1/2 trial completes | ||||
| Also tested for | Advanced Solid Tumor, Metastatic Solid Tumor and 4 more | ||||
| Open drug page | |||||
— |
Phase 1/2 | Mar 2027Phase 1/2 trial completes | |||
| Next date | Mar 2027 · Phase 1/2 trial completes | ||||
| Also tested for | Melanoma, Head and Neck Squamous Cell Carcinoma and 11 more | ||||
| Open drug page | |||||
— |
Phase 1/2 | Aug 2027Phase 1/2 trial completes | |||
| Next date | Aug 2027 · Phase 1/2 trial completes | ||||
| Also tested for | Advanced Solid Tumor, Locally Advanced Solid Tumor and 11 more | ||||
| Open drug page | |||||
— |
Regeneron · Public REGN |
Phase 2 | 30 Jun 2028Phase 2 trial completes | ||
| Next date | 30 Jun 2028 · Phase 2 trial completes | ||||
| Also tested for | Melanoma, Clear-Cell Renal-Cell Carcinoma (ccRCC) and 6 more | ||||
| Open drug page | |||||
— |
Phase 1/2 | 20 Oct 2028Phase 1/2 trial completes | |||
| Next date | 20 Oct 2028 · Phase 1/2 trial completes | ||||
| Also tested for | Advanced Solid Tumor, Unresectable Solid Tumor and 35 more | ||||
| Open drug page | |||||
— |
Phase 1/2 | Jan 2029Phase 1/2 trial completes | |||
| Next date | Jan 2029 · Phase 1/2 trial completes | ||||
| Also tested for | Advanced Solid Tumor, Non Small Cell Lung Cancer and 2 more | ||||
| Open drug page | |||||
— |
Phase 2 | 31 Mar 2029Phase 1/2 trial completes | |||
| Next date | 31 Mar 2029 · Phase 1/2 trial completes | ||||
| Also tested for | Advanced Solid Tumor, Metastatic Solid Tumor and 10 more | ||||
| Open drug page | |||||
— |
AstraZeneca · Public AZN |
Phase 1/2 | 2 Oct 2029Phase 1/2 trial completes | ||
| Next date | 2 Oct 2029 · Phase 1/2 trial completes | ||||
| Also tested for | Melanoma, Non-small Cell Lung Cancer and 7 more | ||||
| Open drug page | |||||
— |
Phase 2 | 31 Dec 2030Phase 2 trial completes | |||
| Next date | 31 Dec 2030 · Phase 2 trial completes | ||||
| Also tested for | Metastatic Pancreatic Cancer | ||||
| Open drug page | |||||
— |
Phase 1/2 | Jun 2032Phase 1/2 trial completes | |||
| Next date | Jun 2032 · Phase 1/2 trial completes | ||||
| Also tested for | Unresectable Melanoma, Metastatic Melanoma and 1 more | ||||
| Open drug page | |||||
— |
Phase 1 | Mar 2027Phase 1 trial completes | |||
| Next date | Mar 2027 · Phase 1 trial completes | ||||
| Also tested for | Advanced Solid Tumors, Metastatic Solid Tumors | ||||
| Open drug page | |||||
— |
Phase 1 | 16 Jul 2027Phase 1 trial completes | |||
| Next date | 16 Jul 2027 · Phase 1 trial completes | ||||
| Also tested for | Alopecia Areata(AA) | ||||
| Open drug page | |||||
— |
Phase 1 | Apr 2028Phase 1 trial completes | |||
| Next date | Apr 2028 · Phase 1 trial completes | ||||
| Also tested for | CLL/SLL, NHL and 8 more | ||||
| Open drug page | |||||
— |
Phase 1 | Jan 2029Phase 1 trial completes | |||
| Next date | Jan 2029 · Phase 1 trial completes | ||||
| Also tested for | Advanced Cancer, Advanced Cancers (Solid Tumors) | ||||
| Open drug page | |||||
— |
Phase 1 | 26 May 2029Phase 1 trial completes | |||
| Next date | 26 May 2029 · Phase 1 trial completes | ||||
| Also tested for | Advanced Solid Tumors | ||||
| Open drug page | |||||
— |
Phase 1 | — | |||
| Also tested for | Solid Tumor, Non Small Cell Lung Cancer and 3 more | ||||
| Open drug page | |||||
— |
Phase 1 | — | |||
| Also tested for | Advanced Cancer, Solid Tumor and 1 more | ||||
| Open drug page | |||||
No drugs match “”.
About this list
- Checked
- 20 of 20 drugs. How we check
- Matches
- The mechanism of checked drugs, and drug names, so a drug not checked yet may be missing.
- Sources
- ClinicalTrials.gov updated 18 Nov 2026 · openFDA updated 17 Nov 2026